InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
60,145.19
(
1.54%
)

Replies to post #1987 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1987 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DewDiligence

07/30/21 12:32 PM

#1988 RE: vinmantoo #1987

ABBV's 2021 Mavyret guidance of $1.9B (lowered from $2.0B) implies about $500M per quarter in 3Q/4Q21. I thought ABBV might drop the full-year guidance to $1.8B (or less), so I'm ok with the $1.9B figure.